Department of Surgery, Yamaga City Medical Center, 511, Yamaga, Kumamoto, 861-0593, Japan.
Department of Radiology, Yamaga City Medical Center, Kumamoto, Japan.
Clin J Gastroenterol. 2021 Feb;14(1):251-257. doi: 10.1007/s12328-020-01286-2. Epub 2020 Nov 12.
Multidisciplinary treatment is recommended for the management of patients with advanced hepatocellular carcinoma (HCC). Some operative decollateralization of extrahepatic feeding arteries with laparotomy have been introduced for HCC. We herein newly develop laparoscopic devascularization (LDEV) to continue transarterial chemoembolization (TACE) for HCC with extrahepatic collateral arteries. A 74-year-old man with multiple huge HCC (4 tumors, 18 cm in diameter) and poor liver function (non-alcoholic steatohepatitis, Child-Pugh score 7) was treated with 6 times of chemoembolization in combination with LDEV, 3 times of ablation therapies, and lenvatinib therapy. His tumor markers were triple positive (AFP, 12,906.5 ng/ml; PIVKA-II, 491,743 mAU/ml; AFP-L3, 91.8%) before treatments; however, they all returned to normal limits. Complete response was achieved according to the modified RECIST criteria. Unfortunately, he died 6 months after the final treatment with no recurrence of HCC due to the postoperative complication of primary lung cancer. LDEV is a useful tool to continue effective TACE, and multidisciplinary treatment including chemoembolization and LDEV can cure advanced HCC patients with extrahepatic collaterals and impaired liver function.
多学科治疗被推荐用于晚期肝细胞癌(HCC)患者的管理。一些剖腹手术中肝外供养动脉的多学科治疗已经被引入到 HCC 的治疗中。我们在此新开发了腹腔镜血管离断术(LDEV),以继续对有肝外侧支循环的 HCC 进行经动脉化疗栓塞(TACE)。一名 74 岁男性患有多个巨大 HCC(4 个肿瘤,直径 18cm)和肝功能不佳(非酒精性脂肪性肝炎,Child-Pugh 评分 7),接受了 6 次化疗栓塞联合 LDEV、3 次消融治疗和仑伐替尼治疗。他的肿瘤标志物在治疗前均为三阳性(AFP,12906.5ng/ml;PIVKA-II,491743mAU/ml;AFP-L3,91.8%);但都恢复到正常范围。根据改良 RECIST 标准,达到完全缓解。不幸的是,由于原发性肺癌的术后并发症,他在最后一次治疗后 6 个月死亡,且 HCC 没有复发。LDEV 是继续有效 TACE 的有用工具,包括化疗栓塞和 LDEV 的多学科治疗可以治愈有肝外侧支和肝功能受损的晚期 HCC 患者。